Enzymatically derived sunflower protein hydrolysate and peptides inhibit NFκB and promote monocyte differentiation to a dendritic cell phenotypeFOOD CHEMISTRYIF9.82020-07-0129PREAI
Multivitamin and Mineral Supplementation Containing Phytonutrients Scavenges Reactive Oxygen Species in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled TrialNUTRIENTSIF52019-01-0513OAAI
Gromwell (Lithospermum erythrorhizon) root extract protects against glycation and related inflammatory and oxidative stress while offering UV absorption capabilityEXPERIMENTAL DERMATOLOGYIF3.12018-07-2916PREAI
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled StudyNUTRIENTSIF52018-01-2515OAAI
Lithospermum erythrorhizon Root and its Naphthoquinones Repress SREBP1c and Activate PGC1 Through AMPKOBESITYIF4.72017-11-225OA
Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trialNUTRITION & METABOLISMIF4.12015-08-068OAAI
Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: Implications for the dietary management of elevated serum triglyceridesJOURNAL OF CLINICAL LIPIDOLOGYIF4.62009-08-0179PREAI
Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes AmyloidogenesisNEURONIF152008-12-01411OA
The role of I1-imidazoline receptors and α2-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome XAGMATINE AND IMIDAZOLINES: THEIR NOVEL RECEPTORS AND ENZYMESIF02006-01-2416PREAI
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome XNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYIF3.12006-01-1723PREAI
Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor-agonist in the spontaneously hypertensive obese rat model of metabolic syndrome XJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82005-07-0112PREAI
Contrasting metabolic effects of antihypertensive agentsJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82003-12-0126PREAI
The role of I1-imidazoline and α2-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome XJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82003-08-0131PREAI